CVS Health (NYSE: CVS) on Wednesday reported fourth-quarter financial results that were stronger than what analysts had anticipated. The company reported earnings
Robust earnings from CVS Health in Q4 pushes stock higher
Categories
Health Care
Exact Sciences Corp. (EXAS): Q4 2019 Earnings Snapshot
-- Exact Sciences Corp. (NASDAQ: EXAS) reported Q4 2019 earnings of $0.54 per share, vs. a loss of $0.35 expected. -- Total
Palatin Technologies, Inc. (PTN): Q2 2020 Earnings Snapshot
-- Palatin Technologies, Inc. (NYSE: PTN) reported a loss of $0.02 per share in the second quarter of 2020, vs $0.01 per share loss
Aethlon Medical (AEMD) Q3 2020 Earnings Snapshot
-- Aethlon Medical (NASDAQ: AEMD) reported third quarter 2020 net loss attributable to company of $820,000 or $0.28 per share vs. a
Allergan (AGN) Q4 results beat; on track to close AbbVie deal in Q1
Allergan plc (NYSE: AGN), which is all set to be acquired by rival drugmaker AbbVie (ABBV), reported a 21% increase in fourth-quarter
Earnings preview: CVS Health (CVS) poised to deliver stable performance in Q4
The pharmacy retail market is witnessing a major transformation, with traditional drugstore operators adopting technology to keep pace with their online counterparts.
AbbVie’s Q4 results beat expectations
AbbVie (NYSE: ABBV) topped revenue and earnings expectations for the fourth quarter of 2019, allowing the stock to gain over 3% in
AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for
Abiomed, Inc. (NASDAQ: ABMD): Q3 2020 Earnings Snapshot
-- Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter
Sanofi (NASDAQ: SNY): Q4 2019 Earnings Snapshot
-- Sanofi (NASDAQ: SNY) reported net loss of EUR 10 million or EUR 0.01 per share for the fourth quarter of 2019,
Cardinal Health (CAH) Q2 2020 Earnings Snapshot
-- Cardinal Health (NYSE: CAH) reported second-quarter 2020 non-GAAP EPS attributable to the company of $1.52 vs. $1.22 expected. -- Revenue increased
Bristol-Myers Squibb (BMY) slips to a loss in Q4 but beats estimates
Bristol-Myers Squibb Company (NYSE: BMY) slipped to a loss in the fourth quarter of 2019 from a profit last year, due to
Regeneron Pharmaceuticals (REGN): Q4 2019 Earnings Snapshot
-- Regeneron Pharmaceuticals (NASDAQ: REGN) reported Q4 2019 earnings of $7.50 per share, vs. $6.92 expected. -- Revenues grew 13% to $2.17
Cigna Corporation (CI): Q4 2019 Earnings Snapshot
-- Cigna Corporation (NYSE: CI) reported Q4 2019 earnings of $4.31 per share, vs. $4.20 expected. -- Revenues totaled $$38 billion, vs.
Bristol-Myers Squib (BMY) set to report Q4 earnings – what is in the offing?
After closing the high-value acquisition of Celgene a few months ago, Bristol-Myers Squib (NYSE: BMY) will be publishing its fourth-quarter results on
Merck & Co. (MRK) Q4 earnings beat estimates, revenue slightly misses
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings for the fourth quarter of 2019. However, the company's sales slightly
Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot
-- Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. -- Total
Humana (NYSE: HUM): Q4 2019 Earnings Snapshot
-- Humana Inc. (NYSE: HUM) reported its fourth-quarter 2019 adjusted earnings of $2.28 per share versus $2.20 per share expected. -- Revenues
Gilead Sciences (GILD) stock falls as Q4 earnings miss estimates
Biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) reported a decline in fourth-quarter earnings, despite a modest increase in revenues. Earnings fell short
McKesson (MCK): Q3 2020 Earnings Snapshot
-- McKesson Corporation (NYSE: MCK) reported its third-quarter 2020 adjusted earnings of $3.81 per share versus $3.56 per share expected. -- Total
Centene Corporation (CNC): Q4 2019 Earnings Snapshot
-- Centene Corporation (NYSE: CNC) reported earnings of $0.73 per share in the fourth-quarter 2019, in line with Wall Street expectation. -- Total revenue